Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection 

BACKGROUND: Resistant staphylococcal organisms remain a serious problem in the treatment of periprosthetic joint infection (PJI). Higher failure rates have been reported when vancomycin was used. The purpose of this study was to assess the clinical dosage, effect, and safety of daptomycin in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Jui, Lee, Mel S., Lee, Chen-Hsiang, Lin, Po-Chun, Kuo, Feng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707892/
https://www.ncbi.nlm.nih.gov/pubmed/29187163
http://dx.doi.org/10.1186/s12879-017-2842-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707892/
https://www.ncbi.nlm.nih.gov/pubmed/29187163
http://dx.doi.org/10.1186/s12879-017-2842-6

Ejemplares similares